Treatment of melanoma of unknown primary in the era of immunotherapy and targeted therapy: A Dutch population‐based study

por Verver, D, van der Veldt, AAM, van Akkooi, ACJ, Verhoef, C, Grünhagen, DJ, Louwman, WJ
Publicado 2019

Cost-effectiveness of adjuvant systemic therapies for patients with high-risk melanoma in Europe: a model-based economic evaluation

por Mulder, E.E.A.P., Smit, L., Grünhagen, D.J., Verhoef, C., Sleijfer, S., van der Veldt, A.A.M., Uyl-de Groot, C.A.
Publicado 2021

Sex differences in patients with gastrointestinal stromal tumours: do they exist and does it affect survival?

por IJzerman, N.S., van Werkhoven, E., Mohammadi, M., Hollander, D. den, Bleckman, R.F., Reyners, A.K.L., Desar, I.M.E., Gelderblom, H., Grünhagen, D.J., Mathijssen, R.H.J., Steeghs, N., van der Graaf, W.T.A.
Publicado 2022

Validation of a clinicopathological and gene expression profile model for sentinel lymph node metastasis in primary cutaneous melanoma

por Mulder, E.E.A.P., Dwarkasing, J.T., Tempel, D., van der Spek, A., Bosman, L., Verver, D., Mooyaart, A.L., van der Veldt, A.A.M., Verhoef, C., Nijsten, T.E.C., Grunhagen, D.J., Hollestein, L.M.
Publicado 2020

The meaning of screening: detection of brain metastasis in the adjuvant setting for stage III melanoma

por Derks, S.H.A.E., de Joode, K., Mulder, E.E.A.P., Ho, L.S., Joosse, A., de Jonge, M.J.A., Verhoef, C., Grünhagen, D.J., Smits, M., van den Bent, M.J., van der Veldt, A.A.M.
Publicado 2022

The age-related impact of surviving sarcoma on health-related quality of life: data from the SURVSARC study

por Drabbe, C., Van der Graaf, W.T.A., De Rooij, B.H., Grünhagen, D.J., Soomers, V.L.M.N., Van de Sande, M.A.J., Been, L.B., Keymeulen, K.B.M.I., van der Geest, I.C.M., Van Houdt, W.J., Husson, O.
Publicado 2021